Related Experiment Video
Updated: Jan 29, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic
Matthew J Armstrong1,2, Farhan Gohar1, Amritpal Dhaliwal1,2
1Liver Unit, Queen Elizabeth University Hospital, Birmingham, UK.
Insights
Echocardiography parameters do not predict survival after transjugular intrahepatic portosystemic stent-shunt (TIPS) in cirrhosis patients. Model for End-Stage Liver Disease and Child-Pugh scores are the best survival predictors. Further study is needed.
Area of Science:
- Cardiology
- Hepatology
- Medical Imaging
Background:
- Cardiac dysfunction is common in cirrhosis patients.
- Limited data exists on echocardiography's role in pre-TIPS assessment.
- This study investigates echocardiography's predictive value for TIPS outcomes.
Purpose of the Study:
- To determine if echocardiography parameters predict survival post-TIPS in cirrhosis.
- To assess the utility of routine echocardiography before TIPS procedures.
Main Methods:
- Retrospective review of 117 cirrhosis patients undergoing TIPS (1999-2016).
- Independent cardiologist review of echocardiography measures, including LVEF and diastolic dysfunction.
- Analysis of predictors for 30-day and overall transplant-free survival.
Main Results:
- Model for End-Stage Liver Disease (MELD) and Child-Pugh scores significantly predicted survival.
- MELD ≥15 indicated a three-fold increased risk of death.
- No echocardiography parameters pre-TIPS correlated with survival outcomes.
- 33% of patients had diastolic dysfunction; 50% had abnormal echocardiograms.
Conclusions:
- Diastolic dysfunction does not predict survival after TIPS in cirrhosis.
- MELD and Child-Pugh scores remain the primary survival predictors.
- Prospective studies are needed to clarify the role of routine echocardiography prior to TIPS.
Background:
Cardiac dysfunction is frequently observed in patients with cirrhosis. There remains a paucity of data from routine clinical practice regarding the role of echocardiography in the pre-assessment of transjugular intrahepatic portosystemic stent-shunt.
Aim:
Our study aimed to investigate if echocardiography parameters predict outcomes after transjugular intrahepatic portosystemic stent-shunt insertion in cirrhosis.
Methods:
Patients who underwent echocardiography and transjugular intrahepatic portosystemic stent-shunt insertion at the liver unit (Birmingham, UK) between 1999 and 2016 were included. All echocardiography measures (including left ventricle ejection fraction; early maximal ventricular filling/late filling velocity ratio, diastolic dysfunction as per British Society of Echocardiography guidelines) were independently reviewed by a cardiologist. Predictors of 30-day and overall transplant free-survival were assessed.
Results:
One Hundred and Seventeen patients with cirrhosis (median age 56 years; 54% alcohol; Child-Pugh B/C 71/14.5%; Model For End-Stage Liver Disease 12) underwent transjugular intrahepatic portosystemic stent-shunt for ascites (n = 78) and variceal haemorrhage (n = 39). Thirty-day and overall transplant-free survival was 90% (n = 105) and 31% (n = 36), respectively, over a median 663 (IQR 385-2368) days follow-up. Model for End-Stage Liver Disease (P < 0.001) and Child-Pugh Score (P = 0.002) significantly predicted 30-day and overall transplant-free survival. Model for End-Stage Liver Disease ≥15 implied three-fold risk of death. Six per cent (n = 7) of patients pre-transjugular intrahepatic portosystemic stent-shunt had a history of ischaemic heart disease and 34% (n = 40) had 1 or more cardiovascular disease risk factors. Fifty per cent (n = 59) had an abnormal echocardiogram and 33% (n = 39) had grade 1-3 diastolic dysfunction. On univariate analysis none of the echocardiography measures pre-intervention were related to 30-day or overall transplant-free survival post-transjugular intrahepatic portosystemic stent-shunt.
Conclusions:
Ventricular, in particular diastolic dysfunction in patients with cirrhosis does not predict survival after transjugular intrahepatic portosystemic stent-shunt insertion. Model for End-Stage Liver Disease and Child-Pugh scores remain the best predictors of survival. Further prospective study is required to clarify the role of routine echocardiography prior to transjugular intrahepatic portosystemic stent-shunt insertion.
More Related Videos
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Shunt Admittances
To model this effect, the method of images is employed. This method involves replacing the Earth with an image conductor that mirrors the original...
Predicting Molecular Geometry
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...